T2DM (Type 2 Diabetes Mellitus)
Metabolic Diseases
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Chipscreen Biosciencestreatment T
Besins HealthcareLaboratory tests
Clinical Trials (2)
Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets
Start: May 2026Est. completion: Jun 2026
N/ANot Yet Recruiting
Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus
Start: Dec 2017Est. completion: Feb 2019
N/ACompleted
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
5h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
23h ago
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Diagnostics Value Consultant(Product Marketing) - Diabetes Care Portfolio
Roche
Taipei
4d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space